Cellular and humoral immunity was studied in 26 patients with subacute sclerosing panencephalitis. Results were compared with those of 14 normal controls and 11 patients suffering from other neurological disorders. It was shown that cellular and humoral immune responses are adequate in subacute sclerosing panencephalitis. The persistently elevated levels of serum immunoglobulin G (IgG) and IgA indicated a persistent infection, and their progressive rise in later stages correlated with the progressive nature of the illness. IgG progressively increased with the clinical stage in the cerebrospinal fluid unaccompanied by a corresponding rise in the measles antibody titer. This suggests that antigenic determinants other than those tested play a role in the production of IgG in the cerebrospinal fluid. The progressive increase in the ratio of cerebrospinal fluid to serum IgG with the advance of the disease suggests synthesis of IgG locally in the central nervous system. Elevated measles antibody titer in serum and cerebrospinal fluid is a consistent aid in the diagnosis of subacute sclerosing panencephalitis. It is more specific in cerebrospinal fluid than in serum. Its level did not vary significantly with the clinical stages or duration of illness. Depressed serum complement activity has been detected in some subacute sclerosing panencephalitis patients in whom serum levels of the third and fourth components of the complement were normal. Whereas the involvement of a measles-like virus in the etiology of SSPE is well substantiated (3, 7, 10, 23) , the pathogenesis of this disease remains unclear. Attempts to uncover factors that heighten the susceptibility of individuals to this virus have been conducted through various approaches. One such approach was immunological. Investigators questioned the competence of the immune system to eliminate the infection. Studies evaluating this competence revealed controversial and sometimes contradictory results, especially regarding cell-mediated immunity (8, 12-14, 20, 24, 26; R. M. Blaese and H. Hofstrand, Arch. Neurol. 32:494-495, 1975 
Cellular and humoral immunity was studied in 26 patients with subacute sclerosing panencephalitis. Results were compared with those of 14 normal controls and 11 patients suffering from other neurological disorders. It was shown that cellular and humoral immune responses are adequate in subacute sclerosing panencephalitis. The persistently elevated levels of serum immunoglobulin G (IgG) and IgA indicated a persistent infection, and their progressive rise in later stages correlated with the progressive nature of the illness. IgG progressively increased with the clinical stage in the cerebrospinal fluid unaccompanied by a corresponding rise in the measles antibody titer. This suggests that antigenic determinants other than those tested play a role in the production of IgG in the cerebrospinal fluid. The progressive increase in the ratio of cerebrospinal fluid to serum IgG with the advance of the disease suggests synthesis of IgG locally in the central nervous system. Elevated measles antibody titer in serum and cerebrospinal fluid is a consistent aid in the diagnosis of subacute sclerosing panencephalitis. It is more specific in cerebrospinal fluid than in serum. Its level did not vary significantly with the clinical stages or duration of illness. Depressed serum complement activity has been detected in some subacute sclerosing panencephalitis patients in whom serum levels of the third and fourth components of the complement were normal.
Subacute sclerosing panencephalitis (SSPE) is a slow virus infection of the central nervous system related to measles. It afflicts children and young adults and usually follows measles infection by several years. It is characterized by a progressive course that ends in disability and death.
Six clinical stages have been recognized (24 Whereas the involvement of a measles-like virus in the etiology of SSPE is well substantiated (3, 7, 10, 23) , the pathogenesis of this disease remains unclear. Attempts to uncover factors that heighten the susceptibility of individuals to this virus have been conducted through various approaches. One such approach was immunological. Investigators questioned the competence of the immune system to eliminate the infection. Studies evaluating this competence revealed controversial and sometimes contradictory results, especially regarding cell-mediated immunity (8, 12-14, 20, 24, 26 (Table 2) . No significant correlation could be found between the duration of illness and the levels of MAT in serum and CSF (Fig. 1) . Immunoglobulins. In each of the 24 SSPE patients tested, the IgG level was higher than the nornal age-specific mean, and in 16 patients it was above the upper limit for age-specific normal range. The mean IgG level in SSPE patients was significantly higher when compared with that of normal controls matched for age and subgroup II controls (Table 3) . IgG levels in stages II and IH were significantly higher than those in in stage I (P < 0.02 and P < 0.05, respectively). Differences between other stages were not statistically significant (Table 4 ). There was no correlation between serum IgG level and the duration of illness (r = -0.12).
CSF IgG level was always within normal limits in subgroup II controls (normal range in our laboratory was 2 to 5.3 mg/dl). It was elevated in 22 of 26 SSPE patients. This elevation was significantly higher in stages III and IV compared with stages I and II (Table 5 ). There was a positive but statistically insignificant correlation between the IgG level and the duration of illness (r = 0.22).
Serum IgA level was above the age-specific mean in 20 to 24 SSPE patients, and in 4 of those 20 it was greater than the age-specific normal range. The mean IgA level of the 24 SSPE patients was significantly higher when compared with that of normal controls matched for age, but it did not differ significantly from that of subgroup II controls (Table 3) . IgA level was significantly higher in stage IV than in stage I (P < 0.05). Differences in other stages were insignificant (Table 4) . IgA level did not correlate with the duration of illness (r = -0. 18) In the CSF IgA was detected in only 6 of the 26 SSPE patients (Table 6 ) and in two subgroup II controls who were suffering from encephalitis (1.7 and 1.45 mg/dl).
Serum IgM was elevated above the upper limit of the age-specific normal range in 2 of 24 SSPE patients. In the remaining patients it was above or close to the normal mean level. The mean IgM level in the 24 SSPE patients was significantly higher than the normal mean, but did not differ significantly from that in subgroup II controls (Table 3) . IgM level did not vary significantly with the clinical stage (Table 4) . It correlated negatively but not significantly with the duration of illness (r = -0.48).
In the CSF IgM was detectable in only 6 of the 26 SSPE patients ( (Fig. 4) . It did not correlate with the duration of illness (r = 0.39). Subgroup II controls had normal serum complement activity. None of the CSF samples had detectable complement activity. DISCUSSION T-cell function. The functional competence of T-lymphocytes in SSPE patients has been questioned (1, 26, 27) . Response to skin testing has been controversial (8, 12, 13). Jabbour et al. (12) have shown a positive response to Candida in all eight patients tested. Only two patients responded to histoplasna and mumps, and none showed a response to measles antigen from two different strains of live measles virus. However, none of their controls showed a response to any of the above-described measles strains. Gerson and Haslam (8) reported on four SSPE patients who did not express delayed responses to six common skin test antigens and failed to become sensitized to dinitrochlorobenzene. They sug- (Fig. 6) suggests that antigenic determinants other than those tested play a role in the production of IgG in the CSF. This suggestion derives support from the demonstration of auto antibodies against a watersoluble brain extract in the CSF of SSPE patients (14) .
MAT. The presence of elevated MAT in the serum and CSF is almost a universal finding in SSPE (4, 25) . The diagnosis, in agreement with the report of Sever et al. (25) .
Horta-Barbosa et al. (11) that CSF HI levels were also significantly increased in stages III and IV when compared with stage II, using the multiple-range test. Our study did not show a significant variation of the serum and CSF MAT with the clinical stage when the log2 geometric means of MAT in each stage were compared. This is in agreement with the study of Legg (17) , who found no significant rise in the MAT in the serum of 22 SSPE patients as their disease progressed. This and the lack of correlation of MAT with the duration of illness suggest that CF and HI measles antibodies are not necessarily involved in the pathogenesis of SSPE. This suggestion gains support from a report on the occurrence of SSPE in a patient with agammaglobulinemia who lacked measles antibodies in his serum and CSF (28) .
Complement. An interesting finding is the demonstration of low complement activity in the sera of some SSPE patients in the presence of normal C3 and C4 values (Fig. 2, 3, and 4) . This finding could be explained by one or more of the following: (i) alteration in vitro, e.g., improper handling; (ii) increased consumption in vivo, e.g., immune complex diseases; and (iii) decreased synthesis, e.g., inborn errors. We are currently investigating these possibilities. 
